{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:43:17Z","timestamp":1778254997526,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,26]]},"DOI":"10.7759\/cureus.30721","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T16:09:49Z","timestamp":1666800589000},"source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and Safety of Intravenous Insulin in Treatment of Patient With Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Kareema S","family":"Alshurtan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Alnizari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadi","family":"Aldarwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali A","family":"Al-Tufaif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson MA","year":"2014","unstructured":"Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014, 383:69-82. 10.1016\/S0140-6736(13)60591-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.34172\/hpp.2020.18","article-title":"Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis","volume":"10","author":"Mobasseri M","year":"2020","unstructured":"Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020, 10:98-115.","journal-title":"Health Promot Perspect"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2010.05.011","article-title":"Epidemiology of type 1 diabetes","volume":"39","author":"Maahs DM","year":"2010","unstructured":"Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010, 39:481-97. 10.1016\/j.ecl.2010.05.011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016587","article-title":"Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review","volume":"7","author":"Fazeli Farsani S","year":"2017","unstructured":"Fazeli Farsani S, Brodovicz K, Soleymanlou N, Marquard J, Wissinger E, Maiese BA. Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review. BMJ Open. 2017, 7:e016587. 10.1136\/bmjopen-2017-016587","journal-title":"BMJ Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0165-1","article-title":"Diabetic ketoacidosis","volume":"6","author":"Dhatariya KK","year":"2020","unstructured":"Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020, 6:40. 10.1038\/s41572-020-0165-1","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.10.2384","article-title":"Mortality in childhood-onset type 1 diabetes: a population-based study","volume":"28","author":"Dahlquist G","year":"2005","unstructured":"Dahlquist G, K\u00e4ll\u00e9n B. Mortality in childhood-onset type 1 diabetes: a population-based study. Diabetes Care. 2005, 28:2384-7. 10.2337\/diacare.28.10.2384","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S50516","article-title":"Management of adult diabetic ketoacidosis","volume":"7","author":"Gosmanov AR","year":"2014","unstructured":"Gosmanov AR, Gosmanova EO, Dillard-Cannon E. Management of adult diabetic ketoacidosis. Diabetes Metab Syndr Obes. 2014, 7:255-64. 10.2147\/DMSO.S50516","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-020-00397-0","article-title":"Management of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus","volume":"22","author":"Castellanos L","year":"2020","unstructured":"Castellanos L, Tuffaha M, Koren D, Levitsky LL. Management of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus. Paediatr Drugs. 2020, 22:357-67. 10.1007\/s40272-020-00397-0","journal-title":"Paediatr Drugs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101318","article-title":"\"100 Years of progress in understanding insulin, its mechanism of action, and its roles in disease and diabetes therapy\"","volume":"52","author":"Kahn CR","year":"2021","unstructured":"Kahn CR. \"100 Years of progress in understanding insulin, its mechanism of action, and its roles in disease and diabetes therapy\". Mol Metab. 2021, 52:101318. 10.1016\/j.molmet.2021.101318","journal-title":"Mol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011281.pub2","article-title":"Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis","author":"Andrade-Castellanos CA","year":"2016","unstructured":"Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev. 2016, CD011281. 10.1002\/14651858.CD011281.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2008.07.023","article-title":"Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis?","volume":"53","author":"Mazer M","year":"2009","unstructured":"Mazer M, Chen E. Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis?. Ann Emerg Med. 2009, 53:259-63. 10.1016\/j.annemergmed.2008.07.023","journal-title":"Ann Emerg Med"},{"key":"ref12","article-title":"Systematic review with meta-analysis: Subcutaneous insulin glargine coadministration for diabetic ketoacidosis [Spanish]","volume":"152","author":"Andrade-Castellanos CA","year":"2016","unstructured":"Andrade-Castellanos CA, Colunga-Lozano LE. Systematic review with meta-analysis: Subcutaneous insulin glargine coadministration for diabetic ketoacidosis [Spanish]. Gac Med Mex. 2016, 152:761-9.","journal-title":"Gac Med Mex"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.endinu.2017.08.005","article-title":"Transition from intravenous insulin to subcutaneous long-acting insulin in critical care patients on enteral or parenteral nutrition","volume":"64","author":"Ramos A","year":"2017","unstructured":"Ramos A, Zapata L, Vera P, Betbese AJ, P\u00e9rez A. Transition from intravenous insulin to subcutaneous long-acting insulin in critical care patients on enteral or parenteral nutrition. Endocrinol Diabetes Nutr. 2017, 64:552-6. 10.1016\/j.endinu.2017.08.005","journal-title":"Endocrinol Diabetes Nutr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton B","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, et al.. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015, 162:777-84. 10.7326\/M14-2385","journal-title":"Ann Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1635-z","article-title":"Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients","volume":"61","author":"Razavi Z","year":"2018","unstructured":"Razavi Z, Maher S, Fredmal J. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients. Endocrine. 2018, 61:267-74. 10.1007\/s12020-018-1635-z","journal-title":"Endocrine"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2009.00536.x","article-title":"Low dose (0.05 units\/kg\/h) is comparable with standard dose (0.1 units\/kg\/h) intravenous insulin infusion for the initial treatment of diabetic ketoacidosis in children with type 1 diabetes-an observational study","volume":"11","author":"Puttha R","year":"2010","unstructured":"Puttha R, Cooke D, Subbarayan A, et al.. Low dose (0.05 units\/kg\/h) is comparable with standard dose (0.1 units\/kg\/h) intravenous insulin infusion for the initial treatment of diabetic ketoacidosis in children with type 1 diabetes-an observational study. Pediatr Diabetes. 2010, 11:12-7. 10.1111\/j.1399-5448.2009.00536.x","journal-title":"Pediatr Diabetes"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2006.00786.x","article-title":"Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients","volume":"60","author":"Ers\u00f6z HO","year":"2006","unstructured":"Ers\u00f6z HO, Ukinc K, K\u00f6se M, Erem C, Gunduz A, Hacihasanoglu AB, Karti SS. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. Int J Clin Pract. 2006, 60:429-33. 10.1111\/j.1368-5031.2006.00786.x","journal-title":"Int J Clin Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.05.010","article-title":"Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis","volume":"117","author":"Umpierrez GE","year":"2004","unstructured":"Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, E Kitabchi A. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004, 117:291-6. 10.1016\/j.amjmed.2004.05.010","journal-title":"Am J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.08.015","article-title":"Insulin infusion responses in diabetic ketoacidosis alone and with a mixed hypochloremic alkalosis","volume":"13","author":"Gupta D","year":"2019","unstructured":"Gupta D, Prasad A, Siddiqui F, Sitaula S, Albert SG. Insulin infusion responses in diabetic ketoacidosis alone and with a mixed hypochloremic alkalosis. Diabetes Metab Syndr. 2019, 13:216-21. 10.1016\/j.dsx.2018.08.015","journal-title":"Diabetes Metab Syndr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/12005.5883","article-title":"Effectiveness of insulin glargine on recovery of patients with diabetic ketoacidosis: a randomized controlled trial","volume":"9","author":"Houshyar J","year":"2015","unstructured":"Houshyar J, Bahrami A, Aliasgarzadeh A. Effectiveness of insulin glargine on recovery of patients with diabetic ketoacidosis: a randomized controlled trial. J Clin Diagn Res. 2015, 9:OC01-5. 10.7860\/JCDR\/2015\/12005.5883","journal-title":"J Clin Diagn Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/BF01223272","article-title":"Comparison of continuous and intermittent intravenous insulin therapies for diabetic ketoacidosis","volume":"13","author":"Piters KM","year":"1977","unstructured":"Piters KM, Kumar D, Pei E, Bessman AN. Comparison of continuous and intermittent intravenous insulin therapies for diabetic ketoacidosis. Diabetologia. 1977, 13:317-21. 10.1007\/BF01223272","journal-title":"Diabetologia"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.83109","article-title":"Managing diabetic ketoacidosis in non-intensive care unit setting: role of insulin analogs","volume":"43","author":"Karoli R","year":"2011","unstructured":"Karoli R, Fatima J, Salman T, Sandhu S, Shankar R. Managing diabetic ketoacidosis in non-intensive care unit setting: role of insulin analogs. Indian J Pharmacol. 2011, 43:398-401. 10.4103\/0253-7613.83109","journal-title":"Indian J Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins JP","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003, 327:557-60. 10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197708042970502","article-title":"Diabetic ketoacidosis: low-dose insulin therapy by various routes","volume":"297","author":"Fisher JN","year":"1977","unstructured":"Fisher JN, Shahshahani MN, Kitabchi AE. Diabetic ketoacidosis: low-dose insulin therapy by various routes. N Engl J Med. 1977, 297:238-41. 10.1056\/NEJM197708042970502","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2577","article-title":"Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state","volume":"93","author":"Kitabchi AE","year":"2008","unstructured":"Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008, 93:1541-52. 10.1210\/jc.2007-2577","journal-title":"J Clin Endocrinol Metab"},{"key":"ref26","article-title":"Adult Diabetic Ketoacidosis","author":"Lizzo JM","year":"2022","unstructured":"Lizzo JM, Goyal A, Gupta V. Adult Diabetic Ketoacidosis. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/sjmms.sjmms_478_19","article-title":"Management of diabetic ketoacidosis in adults: a narrative review","volume":"8","author":"Eledrisi MS","year":"2020","unstructured":"Eledrisi MS, Elzouki AN. Management of diabetic ketoacidosis in adults: a narrative review. Saudi J Med Med Sci. 2020, 8:165-73. 10.4103\/sjmms.sjmms_478_19","journal-title":"Saudi J Med Med Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14788","article-title":"The management of diabetic ketoacidosis in adults-an updated guideline from the Joint British Diabetes Society for Inpatient Care","volume":"39","author":"Dhatariya KK","year":"2022","unstructured":"Dhatariya KK. The management of diabetic ketoacidosis in adults-an updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabet Med. 2022, 39:e14788. 10.1111\/dme.14788","journal-title":"Diabet Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/120830-efficacy-and-safety-of-intravenous-insulin-in-treatment-of-patient-with-diabetic-ketoacidosis-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:51Z","timestamp":1707507771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/120830-efficacy-and-safety-of-intravenous-insulin-in-treatment-of-patient-with-diabetic-ketoacidosis-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.30721","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,26]]}}}